PAX8 and renal cell carcinoma: An analysis of PAX2 and PAX8 expression levels in relation to the survival of RCC patients revealed high expression levels of both PAX2 (p < 0.001; Figure 5B) and PAX8 (p = 0.006; Figure 5C) in RCC which were associated with better overall patient survival.